Monday 05th January, 06:50 AM JST TOKYO — German chemical giant Bayer AG applied for a patent in Japan on June 15, 2007, for a technique to generate induced pluripotent stem cells, or iPS cells, from human cells, according to Patent Office data released by Sunday. The application was submitted around three months before a Japanese team led by Kyoto University professor Shinya Yamanaka announced the successful generation of iPS cells from human cells. The data showed that...
[read full story]
powered by 